Pavel O Rumyantsev Selected Research

hemoglobin Sealy

1/2020

[Radioiodine therapy outcome in toxic multinodular goiter patient with concomitant hereditary Hasharon hemoglobinopathy].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pavel O Rumyantsev Research Topics

Disease

2	Thyrotoxicosis 10/2020 - 01/2020
2	Hypothyroidism 10/2020 - 01/2020
1	Graves Disease (Basedow Disease) 10/2020
1	Leiomyoma (Uterine Fibroids) 01/2020
1	Anemia 01/2020
1	Goiter 01/2020
1	Hemoglobinopathies 01/2020
1	Inflammation (Inflammations) 01/2020
1	Neoplasms (Cancer) 02/2011
1	Thyroid Neoplasms (Thyroid Cancer) 02/2011
1	Thyroid Nodule (Nodule, Thyroid) 02/2011

Drug/Important Bio-Agent (IBA)

1	Thyrotropin Receptors (Thyrotropin Receptor)IBA 10/2020
1	Antithyroid Agents (Antithyroid Drugs)IBA 10/2020
1	Dihydrotachysterol (AT 10)IBA 10/2020
1	IodineIBA 01/2020
1	Radioisotopes (Radionuclides)IBA 01/2020
1	hemoglobin SealyIBA 01/2020
1	BilirubinIBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	Immunoglobulin G (IgG)IBA 01/2020
1	Capsules (Microcapsules)IBA 02/2011

Therapy/Procedure

2	Therapeutics 10/2020 - 01/2020
1	Drug Tapering 10/2020
1	Aftercare (After-Treatment) 10/2020